KROS R&D to Revenue
Keros Therapeutics Inc · R&D to Revenue
KROS R&D to Revenue
Latest reported53.12%period ending
KROS FY R&D/Revenue (101.11% → 53.12%)
Latest values, visible window
High-resolution chart · PNG
KROS r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 53.1191% | |
| 4,890.9577% | |
| 89,574.8344% | |
| 0% | |
| 274.3433% | |
| 0% | |
| 173.79% | |
| 101.11% |